• NAD+ Workflows for Stress and Autophagy Assays

  2026-08-30

  Use NAD+ to connect redox state, enzymatic activity, and stress adaptation without treating a metabolic readout as proof of autophagy. This workflow pairs NAD+ measurements with caspase, PARP1, LC3B, ATG7, and H2AX endpoints to improve mechanistic resolution in breast cancer cell models.

• Angiotensin (1-7) Research Workflows

  2026-08-29

  Build reproducible Angiotensin (1-7) assays around Mas receptor biology, peptide stability, and experimentally defined dosing. This guide connects cell, biochemical, and disease-model workflows with practical controls for studying anti-fibrotic, anti-inflammatory, metabolic, and neuroprotective effects.

• Salmonella Targets FAM134B to Block ER-Phagy

  2026-08-28

  A 2025 Nature Communications study identifies the ER-phagy receptor FAM134B as a host defense target manipulated by Salmonella Typhimurium. The work links SopF-dependent disruption of FAM134B oligomerization to reduced ER-phagy, higher intracellular bacterial burden, and more severe disease in FAM134B-deficient mice.

• Honokiol Workflows for NF-κB and T-Cell Assays

  2026-08-28

  Honokiol enables coordinated investigation of NF-κB signaling, oxidative stress, and immune-cell metabolism in cancer and inflammation models. This practical workflow pairs dose-controlled small-molecule perturbation with PKM splicing, ROS, viability, and antitumor-immunity readouts.

• Clarithromycin CYP3A Inhibition Workflows

  2026-08-27

  Build controlled CYP3A inhibition assays for drug-drug interaction research, statin metabolism interaction studies, and translational pharmacokinetics. This workflow combines solvent control, pathway-specific comparators, analytical QC, and troubleshooting for more interpretable results.

• Engineered Esophagus: Large-Animal Study Insights

  2026-08-27

  This Nature Biotechnology study combines an autologous cell-loaded decellularized scaffold with bioreactor conditioning, biodegradable stenting, and vascularizing pleural coverage to reconstruct a circumferential esophageal segment in growing minipigs. The resulting grafts supported oral feeding, progressive neuromuscular and vascular regeneration, and secondary peristalsis, although survival, sample size, and long-term translation remain important limitations.

• Triiodothyronine (T3) in Beige Adipocyte Research

  2026-08-26

  Use Triiodothyronine as a controlled thyroid-receptor perturbation alongside SEMA3E gain- or loss-of-function experiments to connect transcriptional signaling with thermogenic metabolism. This workflow combines dose-controlled T3 exposure, β-catenin pathway controls, RT-qPCR, immunostaining, and oxygen-consumption measurements for more interpretable beige adipocyte assays.

• QX77 Molecular Chaperone Activator Workflow

  2026-08-26

  QX77 connects LAMP2A-centered chaperone-mediated autophagy with Rab11-dependent trafficking and ES-cell differentiation assays. This practical guide separates CMA effects from mitophagy, translates a recent ETS1 study into assay decisions, and provides fresh-solution handling and troubleshooting strategies.

• NAD+ and Energy-Stress Assay Interpretation

  2026-08-25

  Nicotinamide Adenine Dinucleotide (NAD+) is both a redox coenzyme and a signaling substrate that can reshape how energy-stress and autophagy experiments are interpreted. This article connects NAD+ chemistry with the revised AMPK–ULK1 model and presents a practical framework for separating reagent effects from cellular stress responses.

• EdU Imaging Kits (HF594) and the PNI Question

  2026-08-25

  A translational framework for using EdU-based DNA synthesis measurement to strengthen mechanistic studies of pancreatic ductal adenocarcinoma perineural invasion, with emphasis on Schwann cell plasticity, PGE2 signaling, assay design, and preclinical decision-making.

• Mitoxantrone: Mechanism, ABCG2 Resistance & Research

  2026-08-24

  Mitoxantrone is a DNA-intercalating topoisomerase II inhibitor used as an anticancer research compound. Current evidence also shows that ABCG2 inhibition by marein can increase mitoxantrone sensitivity in resistant cancer-cell models, while product handling requires DMSO, light protection, and frozen storage.

• Trifluoperazine 2HCl: From D2 to Translation

  2026-08-24

  Trifluoperazine 2HCl offers a potent entry point into dopamine D2 receptor biology while opening a disciplined path toward immune and cancer research. This thought-leadership guide connects receptor pharmacology, assay design, metabolic evidence, and translational decision-making without overstating what a D2 inhibitor can prove on its own.

• ZK53 and the Mitochondrial Proteostasis Opportunity

  2026-08-23

  ZK53 is a selective human mitochondrial serine protease ClpP activator that converts mitochondrial proteostasis into a tractable anticancer vulnerability. This thought-leadership perspective connects ClpP activation with electron transport chain disruption, cell-cycle control, ferroptosis sensitization, and translational study design.

• Sodium Nitroprusside for Sex-Specific Vascular Studies

  2026-08-22

  Use Sodium Nitroprusside as a controlled nitric oxide donor to separate vascular smooth muscle responsiveness from upstream angiotensin II, sex-hormone, and autonomic effects. This workflow combines fresh-solution handling, ex vivo vessel assays, platelet studies, and sex-stratified interpretation for more reproducible cardiovascular research.

• KR-12 Human Antimicrobial Peptide Workflows

  2026-08-22

  A practical guide to using KR-12 for membrane, biofilm, LPS, and inflammation studies. It connects concentration planning and assay controls with evidence from mouse colitis models, while highlighting the peptide’s narrow-spectrum activity and translational limits.

8422 records 1/562 page Next 12345 下5页 Last page